1 June 2023
Drax Group plc
("Drax" or "the Company")
Symbol: DRX
Notification of Transactions of Directors,
Persons Discharging Managerial Responsibility or Connected Persons
Maturity of Sharesave options
On 15 April 2020, options were granted under the Drax Group plc Sharesave Plan ('the Sharesave Plan'). The 2020 three-year Sharesave Plan options matured on 1 June 2023.Penelope Small, Group Generation Director and a Person Discharging Managerial Responsibility, has notified the Company that on 1 June 2023 she exercised her options to acquire 14,162 ordinary shares at a price of 127.1 pence per share following the maturity of the Sharesave Plan.
The information below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Details of PDMR / person closely associated with them ("PCA") | |
Name |
Penelope Small |
Reason for the notification | |
Position / status |
Group Generation Director |
Initial notification / amendment |
Initial Notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name |
Drax Group plc |
LEI |
549300YPSNTXR4ZHSR98 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument Identification code |
Ordinary shares of 11 16/29 pence GB00B1VNSX38 |
Nature of the transaction |
Exercise of share options under the Drax Group plc Sharesave Plan (three-year contract) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
127.1 pence per share |
14,162 |
Aggregated information - Aggregated volume - Price |
N/A N/A |
Date of the transaction |
1 June 2023 |
Place of the transaction |
XLON |
--ENDS--
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDDSHFBMATMTAMBBJ
==